Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood

Citation
Mm. Tomaszewski et al., Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma in childhood, J AM ACAD D, 40(5), 1999, pp. 857-861
Citations number
21
Categorie Soggetti
Dermatology,"da verificare
Journal title
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
ISSN journal
01909622 → ACNP
Volume
40
Issue
5
Year of publication
1999
Part
2
Supplement
S
Pages
857 - 861
Database
ISI
SICI code
0190-9622(199905)40:5<857:PCKPAL>2.0.ZU;2-R
Abstract
Primary cutaneous Ki-1(CD30) positive anaplastic large cell lymphoma (ALCL) is an unusual tumor in the pediatric population. However, the nodal-based form of the disease compared with other histologic subsets of childhood non -Hodgkin's lymphomas (NHL) more frequently involves skin, soft tissue, and bone. The objective of this article is to determine the histologic and immu nologic characteristics of childhood primary cutaneous Ki-1(CD30) positive ALCL and its prognosis. The clinical data, histologic features and immunohi stochemical profiles of skin biopsy specimens from 3 children with cutaneou s Ki-1(CD30) positive lymphoma were reviewed. A literature search was perfo rmed and disclosed information on 5 childhood cases. The 3 patients with pr imary cutaneous Ki-1(CD30) positive ALCL all presented similarly as rapidly growing masses initially and clinically believed to be infectious/reactive processes. The diagnosis was established on the basis of histopathologic e xamination and immunohistochemical studies. Histologic sections revealed an extensive infiltrate of tumor cells extending throughout the entire dermis into the subcutaneous fat with frank ulceration in 1 patient. No significa nt epidermotropism was noted. Tumor cells exhibited striking cellular pleom orphism and a high mitotic rate with numerous atypical mitoses. Inflammator y cells were: present in all patients. The tumor cells stained positively f or Ki-1 antigen (CD30), epithelial membrane antigen, and for T-cell markers (UCHL-1, CD3). One of 3 cases, however, failed to stain for leukocyte comm on antigen (LCA). No clinically apparent adenopathy was observed in any of the patients. In all instances the patients developed recurrent disease in the skin at sites separate from the primary location. None of the patients demonstrated any involvement of lymph nodes, bone marrow, or other organ sy stems. All patients were treated with chemotherapy with good response. Prim ary cutaneous Ki-1(CD30) positive lymphoma is rare in children and is chara cterized by recurrences. The prognosis seems to be favorable.